TTrialPathMatch Me to Trials
← Back to trials
RecruitingSpinal DeformitySpinal Degenerative DisorderSpinal Fusion Failure

The Ailliance Post-Market Clinical Study

Eligible age

18+ yrs

Accepts

All genders

Locations

17 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s). Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.

Sponsor: Medtronic Spinal and Biologics

You may qualify if…

  • ✓ 1. Subject provides written informed consent per institution and/or geographical requirements.
  • ✓ 2. Subject is intended to receive or be treated with an eligible Medtronic Cranial and Spinal Technology (CST) device(s) (see product appendices), used alone or in combination, for a cranial and/or spinal indication(s).
  • ✓ 3. Subject is at least 18 years of age or minimum legal age as required by local regulations.
  • ✓ 4. Subject agrees to complete all required assessments per the Schedule of Events.

You may not qualify if…

  • ✕ 1. Subject is currently enrolled or plans to enroll in concurrent drug/device/biologic trial(s) that may confound this trial's results per investigator assessment (i.e. no required intervention that could affect interpretation of all-around device safety and or performance).
  • ✕ 2. Subject who is, or is expected to be, inaccessible for all required follow-up visits.
  • ✕ 3. Subject with exclusion criteria required by local law.
  • ✕ 4. Subject is considered vulnerable at the time of obtaining consent.

Where it's recruiting

Arizona

Tucson

Arkansas

Little Rock

California

Sacramento · San Francisco

Indiana

Bloomington · Carmel · Indianapolis

Kentucky

Louisville

Maryland

Baltimore

Michigan

Rochester Hills

Minnesota

Minneapolis

Missouri

St Louis

New Jersey

New Brunswick

New York

Buffalo

Ohio

Cleveland · Columbus

Source: ClinicalTrials.gov · NCT05856370 · last updated 2026-08-17